Status:
COMPLETED
Time of Positive Pressure Ventilation in Non-vigorous Infants Born Through Meconium-stained Amniotic Fluid
Lead Sponsor:
University Hospital Padova
Collaborating Sponsors:
University of Padova
Conditions:
Meconium Aspiration Syndrome
Infant, Newborn, Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Background: Meconium stained amniotic fluid (MSAF) complicates 3 to 14% of pregnancies, causing meconium aspiration syndrome (MAS) in 5-10% of neonates born. Due to lack of evidence of benefits of end...
Detailed Description
Background: Meconium stained amniotic fluid (MSAF) complicates 3 to 14% of pregnancies, causing meconium aspiration syndrome (MAS) in 5-10% of neonates born. Due to lack of evidence of benefits of end...
Eligibility Criteria
Inclusion
- Level III NICU consultants, residents, and fellows trained in advanced airway management will be eligible to participate in the study
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
September 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 24 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04076189
Start Date
September 16 2019
End Date
September 24 2019
Last Update
April 6 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera di Padova, University of Padova
Padua, Italy, 35128
2
University of Padova
Padua, Italy